1 |
Julie Chandra CS, Sasi S, Bindu Sharmila TK. Material Applications of Gelatin. Handbook of Biopolymers 2023. [DOI: 10.1007/978-981-16-6603-2_28-1] [Reference Citation Analysis]
|
2 |
Parikh K, Kapadia R, Pai R, Prajapati M, Shevalkar G. Emerging Formulation Technologies Against Malaria Resurgence. Drug Development for Malaria 2022. [DOI: 10.1002/9783527830589.ch3] [Reference Citation Analysis]
|
3 |
Ma X, Leone J, Schweig S, Zhang Y. Botanical Medicines With Activity Against Stationary Phase Bartonella henselae. Infectious Microbes and Diseases 2021;3:158-167. [DOI: 10.1097/im9.0000000000000069] [Reference Citation Analysis]
|
4 |
Chen YJ, Liu H, Zhang SY, Li H, Ma KY, Liu YQ, Yin XD, Zhou R, Yan YF, Wang RX, He YH, Chu QR, Tang C. Design, Synthesis, and Antifungal Evaluation of Cryptolepine Derivatives against Phytopathogenic Fungi. J Agric Food Chem 2021;69:1259-71. [PMID: 33496176 DOI: 10.1021/acs.jafc.0c06480] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
|
5 |
Mensah-kane P, Mensah KB, Antwi AO, Forkuo AD, Ansah C. Cryptolepine, the major alkaloid of Cryptolepis sanguinolenta (Lindl.) Schlechter (Apocynaceae), attenuates early and late-phase symptoms of asthma. Scientific African 2020;9:e00540. [DOI: 10.1016/j.sciaf.2020.e00540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
6 |
Georgilis E, Abdelghani M, Pille J, Aydinlioglu E, van Hest JC, Lecommandoux S, Garanger E. Nanoparticles based on natural, engineered or synthetic proteins and polypeptides for drug delivery applications. International Journal of Pharmaceutics 2020;586:119537. [DOI: 10.1016/j.ijpharm.2020.119537] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
|
7 |
Singh NA, Bhardwaj V, Ravi C, Ramesh N, Mandal AKA, Khan ZA. EGCG Nanoparticles Attenuate Aluminum Chloride Induced Neurobehavioral Deficits, Beta Amyloid and Tau Pathology in a Rat Model of Alzheimer's Disease. Front Aging Neurosci 2018;10:244. [PMID: 30150930 DOI: 10.3389/fnagi.2018.00244] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 12.8] [Reference Citation Analysis]
|
8 |
Dmour I, Taha MO. Natural and semisynthetic polymers in pharmaceutical nanotechnology. Organic Materials as Smart Nanocarriers for Drug Delivery 2018. [DOI: 10.1016/b978-0-12-813663-8.00002-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
|
9 |
Forkuo AD, Ansah C, Mensah KB, Annan K, Gyan B, Theron A, Mancama D, Wright CW. In vitro anti-malarial interaction and gametocytocidal activity of cryptolepine. Malar J 2017;16:496. [PMID: 29282057 DOI: 10.1186/s12936-017-2142-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
|
10 |
Forkuo AD, Ansah C, Pearson D, Gertsch W, Cirello A, Amaral A, Spear J, Wright CW, Rynn C. Identification of cryptolepine metabolites in rat and human hepatocytes and metabolism and pharmacokinetics of cryptolepine in Sprague Dawley rats. BMC Pharmacol Toxicol 2017;18:84. [PMID: 29273084 DOI: 10.1186/s40360-017-0188-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
11 |
Kulandaivelu K, Mandal AKA. Improved bioavailability and pharmacokinetics of tea polyphenols by encapsulation into gelatin nanoparticles. IET Nanobiotechnol 2017;11:469-76. [PMID: 28530198 DOI: 10.1049/iet-nbt.2016.0147] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
|
12 |
Lee EJ, Lim KH. Hardly water-soluble drug-loaded gelatin nanoparticles sustaining a slow release: preparation by novel single-step O/W/O emulsion accompanying solvent diffusion. Bioprocess Biosyst Eng 2017;40:1701-12. [PMID: 28791518 DOI: 10.1007/s00449-017-1825-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
13 |
Yin L, Yuvienco C, Montclare JK. Protein based therapeutic delivery agents: Contemporary developments and challenges. Biomaterials 2017;134:91-116. [PMID: 28458031 DOI: 10.1016/j.biomaterials.2017.04.036] [Cited by in Crossref: 59] [Cited by in F6Publishing: 67] [Article Influence: 9.8] [Reference Citation Analysis]
|
14 |
Sonopo MS, Pillay A, Chibale K, Marjanovic-painter B, Donini C, Zeevaart JR. Carbon-14 radiolabeling and tissue distribution evaluation of MMV390048: Carbon-14 labeling and tissue distribution of MMV390048 MMV390048. J Label Compd Radiopharm 2016;59:680-8. [DOI: 10.1002/jlcr.3445] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
15 |
Sahoo N, Sahoo RK, Biswas N, Guha A, Kuotsu K. Recent advancement of gelatin nanoparticles in drug and vaccine delivery. International Journal of Biological Macromolecules 2015;81:317-31. [DOI: 10.1016/j.ijbiomac.2015.08.006] [Cited by in Crossref: 143] [Cited by in F6Publishing: 150] [Article Influence: 17.9] [Reference Citation Analysis]
|
16 |
Su K, Wang C. Recent advances in the use of gelatin in biomedical research. Biotechnol Lett 2015;37:2139-45. [PMID: 26160110 DOI: 10.1007/s10529-015-1907-0] [Cited by in Crossref: 216] [Cited by in F6Publishing: 177] [Article Influence: 27.0] [Reference Citation Analysis]
|
17 |
Gulzar A, Gai S, Yang P, Li C, Ansari MB, Lin J. Stimuli responsive drug delivery application of polymer and silica in biomedicine. J Mater Chem B 2015;3:8599-622. [DOI: 10.1039/c5tb00757g] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 9.9] [Reference Citation Analysis]
|
18 |
Elzoghby AO. Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research. J Control Release 2013;172:1075-91. [PMID: 24096021 DOI: 10.1016/j.jconrel.2013.09.019] [Cited by in Crossref: 410] [Cited by in F6Publishing: 335] [Article Influence: 41.0] [Reference Citation Analysis]
|